Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 68-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: Sulfa, Naproxen sodium and Doxycycline. Past adverse reactions to the above products included Allergy with Doxycycline, Naproxen sodium and Sulfa. Concurrent medical conditions included Sulfonamide allergy, Allergy to antibiotic, Allergy to NSAIDs and Urinary tract disorder NOS. Concomitant products included Mirabegron (Myrbetriq) from 01-Jan-2024 to an unknown date for Urinary tract disorder NOS. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. Patient experienced similar event from the moderna vaccine not from Pfizer. The event did not cause the patient to seek medical care. There were not any other factors that could have led to the adverse event. No treatment information was reported. This case was linked to MOD-2025-789469 (Patient Link).
Allergy to antibiotic; Allergy to NSAIDs; Sulfonamide allergy; Urinary tract disorder NOS
Myrbetriq